Uri Ladabaum

Back to Profile

Publication Details

  • Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis.

    Ladabaum U, Scheiman JM, Fendrick AM. Am J Med. 2003; 114 (7): 546-54

    To estimate the potential cost-effectiveness of colorectal cancer chemoprevention with cyclooxygenase-2-specific inhibitors (COX-2 inhibitors).

    PubMedID: 12753878

Stanford Medicine Resources:

Footer Links: